Qualitätsmanagementsystem und klinische Bewertung – Reguatorische Voraussetzungskosten
Definition
Medical device registration in Germany (via BfArM) requires: (1) ISO 13485 Quality Management System certification; (2) Clinical Evaluation Report (all device classes); (3) Authorized Representative (if non-EU manufacturer); (4) PRRC appointment; (5) Post-Market Surveillance system; (6) UDI assignment and labeling. Each prerequisite requires specialized expertise, documentation, and audit time. Manual preparation leads to rework and consultant overruns.
Key Findings
- Financial Impact: €50,000–€150,000 typical regulatory consulting/CRO costs. ISO 13485 audit: €10,000–€30,000. Clinical Evaluation Report: €20,000–€80,000 depending on device complexity and clinical data availability. 6–12 month internal delay = €100,000–€300,000+ opportunity cost (lost revenue during approval window).
- Frequency: One-time per device class; then annual compliance maintenance (€5,000–€15,000/year)
- Root Cause: High regulatory complexity; insufficient in-house expertise; manual document management; external dependency on notified bodies and clinical consultants
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Accessible Hardware Manufacturing.
Affected Stakeholders
Regulatory Affairs, Quality Assurance, Clinical/Medical Affairs, Finance/Budget
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.